Lytix Biopharma is focused on lytic peptides derived from lactoferrin. The company's core technology is based on the identification of the pharmacophore of bioactive peptides and the subsequent creation of small mimetic molecules as drug leads using medicinal chemistry approaches. Its small molecules show antimicrobial and anticancer activity in early studies, as well as good specificity.
PO Box 6447
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
